Circulating elastin fragments drive systemic aging: Where do pro-aging elastin fragments come from? A mini-review.
Key claim: Circulating elastin fragments released from mechanically loaded tissues (aorta and large arteries, lungs, and skin) via age-related elastolysis act as potent mediators of inflammaging and systemic aging.
Abstract
Circulating elastin fragments have emerged as potent mediators of inflammaging and systemic aging, yet a fundamental question persists: which anatomical compartments serve as the primary sources of these fragments during aging? Elastin is a structurally restricted protein distributed unevenly across tissues, predominantly at sites subject to repetitive mechanical loading, such as the aorta and large arteries, the lungs, and the skin. It is speculated that age-driven structural deterioration within these compartments, spanning arteriosclerosis, emphysema, and dermal extracellular matrix (ECM) remodeling, coupled with upregulated elastolytic protease activity (including neutrophil elastase, MMP-2, MMP-9, and MMP-12), sustains a chronic, low-grade release of bioactive elastin fragments into the circulation, thereby fueling inflammaging and systemic aging. Delineating the relative contributions of each source is therefore more than an anatomical exercise; it establishes a mechanistic framework for designing tissue-targeted interventions capable of disrupting the ECM-inflammaging axis. This mini-review examines the principal anatomical sources of circulating elastin fragments and the elastolytic enzymes responsible for their generation.
Why this matters
Mechanistic aging accounts typically treat ECM aging as a local tissue problem (stiffness, fibrosis, loss of elasticity) and inflammaging as a separate cytokine/SASP phenomenon. This mini-review proposes that elastin breakdown in a few mechanically loaded tissues generates circulating peptide fragments that themselves act as pro-aging mediators, offering a concrete molecular bridge between matrix deterioration and systemic inflammation and a tissue-targeted framework for where interventions would need to act.